PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.

Published in:

Cell Death & Disease, 2022, v. 13, n. 11, p. 1, doi. 10.1038/s41419-022-05389-1

By:

• Liao, Yunfei;
• Luo, Zaili;
• Lin, Yifeng;
• Chen, Huiyao;
• Chen, Tong;
• Xu, Lingli;
• Orgurek, Sean;
• Berry, Kalen;
• Dzieciatkowska, Monika;
• Reisz, Julie A.;
• D'Alessandro, Angelo;
• Zhou, Wenhao;
• Lu, Q. Richard

Publication type:

Article